Vaxcyte 

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$53.83-$121.05
Market Cap
$10.7B
Shares Short
11M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
-$22.9M
Diluted EPS
-$4.60

News

See more

Yahoo Finance • 11 months ago

Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants

Yahoo Finance • last year

Vaxcyte Appoints Jacks Lee to Board of Directors

Yahoo Finance • last year

Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates

Yahoo Finance • last year

Vaxcyte Doses First Participants in Phase 1/2 Clinical Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Adults

About

CEO
Mr. Grant E. Pickering M.B.A.
CFO
Mr. Andrew L. Guggenhime M.B.A.
Address
825 Industrial Road, San Carlos, CA, United States, 94070
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
254